RGTI Insider Sale: 75,000 Shares Sold; 28,812 Warrants Fully Vested
Rhea-AI Filing Summary
Rigetti Computing director Michael S. Clifton reported insider sales on 09/12/2025 under a Rule 10b5-1 plan. Clifton sold a total of 75,000 shares in two transactions: 25,000 shares at $17.00 and 50,000 shares at a weighted average price of $20.003. After these sales the filing shows beneficial ownership of 653,766 shares. The filing also reports ownership of 28,812 warrants with an $11.50 exercise price; the warrants and related underlying shares are noted as fully vested and exercisable. The Form 4 was signed by an attorney-in-fact on 09/15/2025.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating prearranged trades rather than opportunistic insider timing
- Warrants (28,812) are fully vested and exercisable, clarifying future potential for exercise-based liquidity or dilution
Negative
- Director sold 75,000 shares on 09/12/2025, which reduces his reported beneficial ownership
- Weighted-average sale price includes higher-price executions ($20.00–$20.02), showing partial disposition at varying price points
Insights
TL;DR: Director sold 75,000 RGTI shares via a 10b5-1 plan; remaining beneficial stake ~653,766 shares; warrants fully vested.
The reported sale of 75,000 shares on a single date under an established Rule 10b5-1 plan indicates a prearranged disposition rather than an ad-hoc trade. The transactions occurred at $17.00 and a weighted average of $20.003, reducing reported beneficial ownership to 653,766 shares. From a capital markets perspective, sales under 10b5-1 plans typically carry less informational content about insider views, but the size of the sale relative to holdings is relevant for modeling insider liquidity and potential downward supply pressure.
TL;DR: Trades executed under a documented 10b5-1 plan and signed by an attorney-in-fact; warrants are fully exercisable.
The filing documents compliance with procedural safeguards: adoption of a Rule 10b5-1 plan (March 10, 2025) and execution via attorney-in-fact signature, which supports formality and advance planning. The existence of 28,812 warrants at an $11.50 exercise price, noted as fully vested and exercisable, is important for assessing potential future dilution. No other governance issues or amendments are reported in this Form 4.
FAQ
What insider transactions did Michael S. Clifton report for RGTI?
How many RGTI shares does Clifton beneficially own after these trades?
Does Clifton hold any derivative securities in RGTI?
Were the trades part of a prearranged plan?
Who signed the Form 4?